首页> 外文期刊>Clinical and vaccine immunology: CVI >Mucosal, Cellular, and Humoral Immune Responses Induced by Different Live Infectious Bronchitis Virus Vaccination Regimes and Protection Conferred against Infectious Bronchitis Virus Q1 Strain
【24h】

Mucosal, Cellular, and Humoral Immune Responses Induced by Different Live Infectious Bronchitis Virus Vaccination Regimes and Protection Conferred against Infectious Bronchitis Virus Q1 Strain

机译:不同的活感染性支气管炎病毒疫苗接种制度诱导的粘膜,细胞和体液免疫反应以及对传染性支气管炎病毒Q1株的保护作用

获取原文
           

摘要

The objectives of the present study were to assess the mucosal, cellular, and humoral immune responses induced by two different infectious bronchitis virus (IBV) vaccination regimes and their efficacy against challenge by a variant IBV Q1. One-day-old broiler chicks were vaccinated with live H120 alone (group I) or in combination with CR88 (group II). The two groups were again vaccinated with CR88 at 14 days of age (doa). One group was kept as the control (group III). A significant increase in lachrymal IgA levels was observed at 4 doa and then peaked at 14 doa in the vaccinated groups. The IgA levels in group II were significantly higher than those in group I from 14 doa. Using immunohistochemistry to examine changes in the number of CD4+ and CD8+ cells in the trachea, it was found that overall patterns of CD8+ cells were dominant compared to those of CD4+ cells in the two vaccinated groups. CD8+ cells were significantly higher in group II than those in group I at 21 and 28 doa. All groups were challenged oculonasally with a virulent Q1 strain at 28 doa, and their protection was assessed. The two vaccinated groups gave excellent ciliary protection against Q1, although group II's histopathology lesion scores and viral RNA loads in the trachea and kidney showed greater levels of protection than those in group I. These results suggest that greater protection is achieved from the combined vaccination of H120 and CR88 of 1-day-old chicks, followed by CR88 at 14 doa.
机译:本研究的目的是评估由两种不同的传染性支气管炎病毒(IBV)疫苗接种方案诱导的粘膜,细胞和体液免疫反应,以及它们对抗变种IBV Q1的功效。用单独的活H120(I组)或与CR88组合(II组)给1天大的肉仔鸡接种。两组均在14天龄时再次接种CR88(doa)。保留一组作为对照(第三组)。在接种组中,泪腺IgA水平显着增加,出现在4 doa,然后在14 doa达到峰值。 II组的IgA水平明显高于14 doa的Ig组。使用免疫组织化学检查气管中CD4 + 和CD8 + 细胞数量的变化,发现CD8 + 细胞的总体模式与两个接种组的CD4 + 细胞相比,它们占优势。在21和28 doa时,第二组的CD8 + 细胞显着高于第一组。所有组均在28 doa处用强毒性Q1菌株进行眼鼻挑战,并评估其保护作用。尽管II组的组织病理学损伤评分和气管和肾脏中的病毒RNA含量显示出比I组更高的水平,但两个疫苗接种组对Q1的纤毛防护效果极佳。 1天大的雏鸡的H120和CR88,其次是14 doa的CR88。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号